| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Richard D. Nanula CEO | OTC PINK Exchange | CA54960E2033 ISIN |
| US Country | 2 Employees | - Last Dividend | 26 Feb 2024 Last Split | - IPO Date |
Lucy Scientific Discovery Inc., originally incorporated as Hollyweed North Cannabis Inc., is a pioneering enterprise in the burgeoning field of psychotropic medicines, focusing primarily on the research, manufacturing, and commercialization of psychedelic-based products. With its establishment in 2017 and headquartered in Victoria, Canada, the company stands at the forefront of the early stage psychotropics contract manufacturing industry. In May 2021, in a strategic rebranding initiative, the company transitioned to its current name to better reflect its mission and the scope of its operations. Lucy Scientific Discovery Inc. is dedicated to leveraging cutting-edge technology and scientific methods to develop a range of biological materials and pharmaceutical products, targeting the rapidly expanding market for therapeutic psychedelic substances.
Lucy Scientific Discovery Inc. offers a variety of biological raw materials geared towards the burgeoning field of psychedelic research and therapy. These materials serve as the foundation for developing active pharmaceutical ingredients (APIs) and finished biopharmaceutical products, catering to the needs of the medical and scientific communities engaging in psychedelic studies.
The company specializes in the production of high-quality, psychedelic-based active pharmaceutical ingredients (APIs) essential for the development and manufacture of therapeutic drugs. These APIs are pivotal for researchers and pharmaceutical companies focused on creating effective treatments for a range of mental health conditions, utilizing the unique properties of psychedelic substances.
Completing its product spectrum, Lucy Scientific Discovery Inc. also manufactures and commercializes finished biopharmaceutical products. These products encompass a range of therapeutic applications, designed to meet the stringent regulatory standards for safety and efficacy in the treatment of various medical conditions through the application of psychedelic compounds.
Beyond its pharmaceutical offerings, Lucy Scientific Discovery Inc. is at the vanguard of developing and producing advanced agricultural grow environments. These environments are engineered for the highly controlled cultivation and replication of plant-based materials. This innovative approach supports the company's research and production capabilities by ensuring a consistent, sustainable supply of high-quality biological materials for their psychedelic product lines.